Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
461 to 480 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immune checkpoints as potential theragnostic biomarkers for epithelial ovarian cancer. | Int J Biol Markers | 2023 | 37518940 | PubTator, text mining | PubMed |
| The pathobiology of follicular lymphoma. | J Clin Exp Hematop | 2023 | 37518274 | PubTator, text mining | PubMed |
| Mouse Models for Human Herpesviruses. | Pathogens | 2023 | 37513800 | PubTator, text mining | PubMed |
| Bridging Pyroptosis and Immunity: A Comprehensive Study of the Pyroptosis-Related Long Non-Coding RNA Signature in Breast Cancer. | Life (Basel) | 2023 | 37511974 | PubTator, text mining | PubMed |
| A Ferroptosis-Related lncRNAs Signature Predicts Prognosis of Colon Adenocarcinoma. | Life (Basel) | 2023 | 37511932 | PubTator, text mining | PubMed |
| Immune System and Hepatocellular Carcinoma (HCC): New Insights into HCC Progression. | Int J Mol Sci | 2023 | 37511228 | PubTator, text mining | PubMed |
| Molecular Evolutionary Landscape of the Immune Microenvironment of Head and Neck Cancer. | Biomolecules | 2023 | 37509156 | PubTator, text mining | PubMed |
| Developing Oncolytic Viruses for the Treatment of Cervical Cancer. | Cells | 2023 | 37508503 | PubTator, text mining | PubMed |
| The role of IFN-γ-signalling in response to immune checkpoint blockade therapy. | Essays Biochem | 2023 | 37503572 | PubTator, text mining | PubMed |
| Plasma TRAIL and ANXA1 in diagnosis and prognostication of pulmonary arterial hypertension. | Pulm Circ | 2023 | 37502145 | PubTator, text mining | PubMed |
| Follicular helper T-cell lymphomas: disease spectrum, relationship with clonal hematopoiesis, and mimics. A report of the 2022 EA4HP/SH lymphoma workshop. | Virchows Arch | 2023 | 37500795 | PubTator, text mining | PubMed |
| T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against HVEM-over-expressing Melanoma Cell Lines. | Anticancer Res | 2023 | 37500142 | PubTator, text mining | PubMed |
| Integration of single-cell regulon atlas and multi-omics data for prognostic stratification and personalized treatment prediction in human lung adenocarcinoma. | J Transl Med | 2023 | 37491302 | PubTator, text mining | PubMed |
| Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy. | J Transl Med | 2023 | 37491263 | PubTator, text mining | PubMed |
| The effect of matrices on the gene expression profile of patient-derived head and neck carcinoma cells for in vitro therapy testing. | Cancer Cell Int | 2023 | 37488620 | PubTator, text mining | PubMed |
| A network approach to define the predictive role of immune profile on tumor response and toxicity of anti PD-1 single agent immunotherapy in patients with solid tumors. | Front Immunol | 2023 | 37483633 | PubTator, text mining | PubMed |
| HBV-associated DLBCL of poor prognosis: advance in pathogenesis, immunity and therapy. | Front Immunol | 2023 | 37483605 | PubTator, text mining | PubMed |
| Paraneoplastic or not? Sirtuin 2 in anti-N-methyl-d-aspartate receptor encephalitis. | Eur J Neurol | 2023 | 37483157 | PubTator, text mining | PubMed |
| A five-collagen-based risk model in lung adenocarcinoma: prognostic significance and immune landscape. | Front Oncol | 2023 | 37476379 | PubTator, text mining | PubMed |
| Analysis of Aldehyde Dehydrogenase 2 as a Prognostic Marker Associated with Immune Cell infiltration and Chemotherapy Efficacy in Head and Neck Squamous Cell Carcinoma. | J Cancer | 2023 | 37476181 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=24